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Purpose: Prostate brachytherapy is an important treatment technique for patients with localized
prostate cancer. An inflatable rectal ultrasound probe cover is frequently utilized during the procedure
to adjust for unfavorable prostate position relative to the implant grid. However, the inflated cover
causes prostate deformation, which is not accounted for during dosimetric planning. Most of the
therapeutic dose is delivered after the procedure when the prostate and surrounding organs-at-risk are
less deformed. The aim of this study is to quantify the potential dosimetry changes between the initial
plan (prostate deformed) and the more realistic dosimetry when the prostate is less deformed without
the cover.
Methods: The authors prospectively collected the ultrasound images of the prostate immediately
preceding and just after inflation of the rectal probe cover from thirty-four consecutive patients under-
going real-time planning of I-125 permanent seed implant. Manual segmentations of the deformed
and undeformed images from each case were used as the input for model training to generate the
initial transformation of a testing patient. During registration, the pixel-to-pixel transformation was
further optimized to maximize the mutual information between the transferred deformed image
and the undeformed images. The accuracy of image registration was evaluated by comparing the
displacement of the urethra and calcification landmarks and by determining the Dice index between
the registered and manual prostate contours. After registration, using the optimized transformation,
the implanted seeds were mapped from the deformed prostate onto the undeformed prostate. The dose
distribution of the undeformed anatomy, calculated using the VariSeed treatment planning system,
was then analyzed and compared with that of the deformed prostate.
Results: The accuracy of image registration was 1.5±1.0 mm when evaluated by the displacement
of calcification landmarks, 1.9±1.1 mm when characterized by the displacement of the centroid
of the urethra, and 0.86±0.05 from the determination of the Dice index of prostate contours. The
magnitude of dosimetric changes was associated with the degree of prostate deformation. The prostate
coverage V100% dropped from 96.6±1.7% on prostate-deformed plans to 92.6±3.8% (p < 0.01) on
undeformed plans, and the rectum V100% decreased from 0.48±0.39 to 0.06±0.14 cm3 (p < 0.01).
The dose to the urethra increased, with the V150% increasing from 0.02±0.06 to 0.11±0.10 cm3
(p < 0.01) and D1% changing from 203.5±22.7 to 239.5±25.6 Gy (p < 0.01).
Conclusions: Prostate deformation from the inflation of an ultrasound rectal probe cover can signifi-
cantly alter brachytherapy dosimetry. The authors have developed a deformable image registration
method that allows for the characterization of dose with the undeformed anatomy. This may be
used to more accurately reflect the dosimetry when the prostate is not deformed by the probe cover.
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NOMENCLATURE
DVH Dose–volume histogram
D100%, D90%, D80% Minimum dose to 100%, 90%, 80%
of the structure volume
IntraOp Intraoperative ultrasound image with the inflation
from ultrasound rectal probe cover and prostate
deformation
PreOp Preoperative ultrasound image with no inflation
from ultrasound rectal probe cover and prostate
deformation
V150%, V100% Volume of the structure receiving 150%
and 100% of the prescribed dose, respectively
1. INTRODUCTION
Prostate brachytherapy using permanent seed implant is an
important treatment technique for prostate cancer.1,2 Multiple
large studies have established permanent implant brachy-
therapy as an effective treatment for early-stage disease.3,4
Toxicity from prostate brachytherapy is correlated with doses
to the urethra5 and rectum.6 One modern implant technique
involves planning, seed loading, and implanting in real time.
In this method, prostate ultrasound images are acquired with
a transrectal ultrasound probe wrapped in an inflated cover to
improve image quality and positioning of the prostate prior
to seed implantation.7 The dose distribution is then optimized
within the planning software by adjusting the placement of
needles within the prostate volume and the distribution of
seeds within each needle. Implantation is guided by superim-
posing the planned needle position onto the guided ultrasound
image, allowing the physician to manipulate the needle until
it closely matches the planned location. The ultrasound rectal
probe cover remains inflated for the duration of this procedure,
resulting in deformation of the prostate volume. Because
the dose distribution is optimized using a deformed image
of the prostate, differences could potentially exist between
the planned dose and the physical dose that is received by
the prostate, urethra, and rectum once the probe cover has
been deflated. We predict that prostate deformation during the
procedure can affect the dosimetry postprocedure without the
inflated probe cover.
The goal of this study is to assess the effect of prostate defor-
mation on brachytherapy dosimetry and to develop a novel
algorithm that can account for this deformation during brachy-
therapy planning. Specifically, a learning based deformable
image registration algorithm was developed to characterize
the voxel-to-voxel correlation between predeformation and
postdeformation images of each patient. With this registration,
the seed positions within the deformed images were mapped to
the undeformed images, allowing for a dosimetric comparison
between the clinical plan and the deformation-free research
plan.
In this study, the undeformed image refers to the image
acquired without inflation of the probe cover. It does not imply
that the anatomy was completely free of deformation from
alternative causes, like the positions of surrounding organs
or the presence of the ultrasound probe itself. The clinical
plan refers to the treatment plan designed using the deformed
prostate images and delivered to the patient, while the research
plan refers to that designed retrospectively using the images of
the undeformed prostate.
2. METHODS
2.A. Patient selection and treatment
This study was approved by the Institutional Review Board
of the University of North Carolina. In detail, thirty-four
patients with a diagnosis of organ-confined prostate cancer
underwent brachytherapy with real-time planning. Selected
characteristics of the studied patients are presented in Table I.
The clinical procedure follows the standards described by the
American Brachytherapy Society for permanent brachyther-
apy of prostate cancer8 with intraoperative planning and ultra-
sound guided needled placement. The details of patients are
presented in Table I. Prescribed doses of 145 or 110 Gy were
selected for monotherapy or boost treatments, respectively.
The procedure was performed under general anesthesia
with the patient in the lithotomy position and a Foley catheter
in place. Transrectal ultrasound was used with an inflatable
cover wrapped around the ultrasound rectal probe to capture
images of the prostate for treatment planning. The preoperative
set of ultrasound images were captured preceding probe cover
inflation and the contouring was performed after the proce-
dure. The cover was then inflated with sonic conductive gel
until the prostate had been raised to the appropriate position
with respect to the implant grid. At this point, the intraop-
erative set of ultrasound images were acquired for treatment
planning. The presence of the gel improves acoustic coupl-
ing between the soft tissue and the transducer, resulting in
an image with superior quality.7 The prostate, urethra, and
rectum were immediately contoured by the physician using
T I. Patient demographic and characteristics.
Median (range)
Median age 61 (48–75)
Tumor stage T1c (T1c–T2c)
Median Gleason score 6 (6–7)
Mean PSA (ng/ml) 6.03 (1.2–20.6)
Mean prostate volume (cm3) 34.15 (17.93–72.94)
Median number of seeds 65 (47–105)
Median number of needles 21 (15–31)
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the deformed images. The following dosimetric goals were
used while planning: prostate V100% ≥ 95%; D90% between
100% and 115% of prescription dose; urethra V150% ≤ 1 cm3;
rectum V100% ≤ 1 cm3.
For treatment planning, the optimization of needles and
seeds consisted of three stages. First, a modified peripheral
loading method was used to automatically generate a prelim-
inary plan. This method selectively spares the center of the
prostate and prioritizes needles placed 5 mm from the outline
of the prostate. Second, a dose optimization method was used
to strategically adjust source number and distribution to maxi-
mally cover the target and spare the organs at risk (OARs)
while maintaining the same locations of needles generated by
the preliminary plan.9 Third, the physician manually adjusted
the sources and needles to create the final plan. The seeds and
spacers were then manually loaded into the needles according
to the treatment plan.
Needle placement during the procedure was guided us-
ing ultrasound. When the physical location of the needle
differed greatly from the planned location, the physician repo-
sitioned the needle. Minor differences between the physical
and planned needle placements were recorded in the treatment
planning software as the procedure took place.7 This record
gives the physician the opportunity to compensate for any
deviations between planned and up-to-date dosimetries by
shifting the needle position in next implant or supplementing
with additional needles. Tracing and real time dose reconstruc-
tion were embedded functions in the commercial treatment
planning software (VariSeed 8.1).
2.B. Equipment
A 3D intraoperative computer planning system (VariSeed
ver 8.1; Varian, Inc., Palo Alto, CA) was used for treatment
planning and implantation of seeds. Ultrasound images were
acquired with a B&K model 1900 biplanar ultrasound machine
(B&K Medical, Wilmington, MA). The image resolution was
1 mm in the patient superior–inferior direction and 0.12 mm
in the remaining two directions. The ultrasound rectal probe
cover was a common type made by CIVCO (Coralville, IA).
The probe cover has two layers and an attachment specifi-
cally for connecting a syringe to inflate the cover with sonic
conductive gel. Loose I-125 seeds (Best Medical International,
Springfield, VA and Bard Medical Division, Covington, GA),
with an average seed activity of 0.384 ± 0.009 mCi (0.488
±0.011 U), were used with sterile 18-gauge needles. The seeds
were delivered by ultrasound-guided transperineal insertion
using the standard 0.5 cm gridded template.
2.C. Deformable image registration and seed mapping
In order to map the seeds from the deformed intraoperative
(IntraOp) ultrasound images used for the clinical plan onto
the undeformed preoperative (PreOp) ultrasound images, a
deformable image registration was needed for correlating the
voxels between the deformed and undeformed images. Due to
the low image contrast and signal to noise ratio, registration
between the ultrasound images is a complex problem that has
not been thoroughly studied.10–12
A hybrid approach was developed in order to map the vox-
els between the deformed and undeformed prostate. Threefold
cross-validation was used in the stage of contour initializa-
tion.13 Patients were randomly assigned to one of the three
groups (A, B, and C). The process consisted of three rounds.
In each round, two groups were allocated as the training set,
with the remaining group used exclusively as the testing set.
The registration part consisted of three steps. First,
the contour-to-contour transformations between the binary
deformed and undeformed images were found for each patient
within the training set. Specifically, the detected centers of the
probes in both the deformed and undeformed images were
defined as the image origin (0, 0, 0) for each patient, and a
cylindrical coordinate system was established along the z-axis
(superior–inferior direction) for deformed and undeformed
images. The best transformation T ′was found between the two
binary images (contours) using mutual information between
the deformed and undeformed images from the same patient.































where IIntraOp and IPreOp are the binary deformed and unde-





the mutual information of IIntraOp and IPreOp, H (I) is the Shan-
non entropy of image I,14 H (I,J) is the joint entropy of images
I and J, and RT (I,J) is a registration from J to I with the
transformation T . Note that the initial value of T is an identity
matrix for the binary images and the optimal transformation
T ′ is the best transformation between the binary deformed and
undeformed images. Second, the average of the best trans-
formation among patients within the training set was then
assigned as the initial coordinate transformation T0 for each
patient within the testing set. Last, the deformed and unde-
formed intensity images were registered on the whole prostate.
This was done by detecting the probe centers and establish-
ing the cylindrical coordinate systems for the deformed and
undeformed images of patients belonging to the testing group.
With the initialization T0, the best transformation T between
both the cylindrical coordinate systems of the two intensity
images was determined by maximizing the mutual information
of the transferred deformed and undeformed images, similar
to Eqs. (1) and (2).15 Despite using only the binary image for
registration of the training set, all intensity information was
used for registration of the testing set. Please note that during
the optimization of this step, IIntraOp and IPreOp in Eqs. (1) and
(2) are the deformed and undeformed intensity images of the
testing patient, T0 is used as the initial transformation, which
is derived from the training set, and the optimal transforma-
tion T ′ is the best transformation between the deformed and
undeformed images of the current testing patient. Thus, the
pixel to pixel correspondence on both the cylindrical coor-
dinate systems was established after an optimal coordinate
transformation was found. Using this method, we were able
to map the brachytherapy implanted seeds from the deformed
prostate onto the undeformed prostate.
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It is noted that the initial transformation T0, computed
by averaging known transformations, can be applied to
a new patient not in training set. The initialization can
prevent the registration algorithm from being confined by
a local maximum while also reducing the iteration time
before convergence. Additionally, the described method can
be used on a new patient without the need to segment
the undeformed intensity images. The contour of the cur-
rent patient was not used during the image registration
for a given patient. Optimization using Eqs. (1) and (2)
parameterized the deformation vector field (DVF) as an
modified affine transformation on cylindrical coordinates
and regularized by the smoothness of DVF. The transfor-
mation is considered linear on the cylindrical coordinate
system and nonlinear on the Cartesian coordinate system.
A summary of the algorithm is illustrated in Algorithm I
of the Appendix. By using the transformation found from
the registration, we can transfer the seeds on the intra-
operative image to the corresponding preoperative image.
With the transferred seeds, brachytherapy dosimetry of the
undeformed prostate was calculated using the VariSeed
planning software and manual contour on the preoperative
image. This plan was then compared to the dosimetry of
the clinical plan with the deformed prostate. The inflation
of the ultrasound cover was relatively constant along the
longitudinal direction and used as an indicator of prostate
deformation. The amount of inflation was determined on the
axial slice in which the area of the prostate was greatest
by measuring the distance between the anterior surface of
ultrasound probe and the inflated cover. The workflow of
seed mapping and dosimetry comparison is summarized
in Fig. 1.
2.D. Evaluation of image registration accuracy
Three methods were used to evaluate the accuracy of image
registration. The manual contour on the IntraOp image was
transferred back to the PreOp image using the transformation
F. 1. The workflow of seed mapping and dosimetry comparison.
found from deformable image registration. The Dice index was
calculated using the transferred contour and original manual
contour on each PreOp image to evaluate the performance of
our image registration method. This serves as a preliminary
quality assurance of registration. To further check the pixel
to pixel correspondence inside the contour, the calcification
points were identified and used as landmarks. The calcifica-
tions have been found to be the reliable markers of prostate
positioning in cone beam CT guided radiotherapy16 and quan-
tify the accuracy of image registration.17 Among 34 patients,
32 patients had visible calcifications. The average number of
calcification points of these 32 patients was 1.8± 1.1 (1–4)
per patient. Overall 57 calcifications were used in this evalua-
tion. The calcifications were contoured as small structures in
both the IntraOP and PreOp images. After the IntraOp image
was registered on the PreOp image, the calcification contour
from the IntraOp image was transferred to the PreOp image.
The displacement between two calcification landmarks was
measured as the distance of the centroids of two contours.
Last, the urethra was used to evaluate the accuracy of image
registration due to its relatively stable position in the prostate.
The urethra was contoured ∼3–5 slices (slice thickness is
1 mm) superior and inferior to the prostate contour, depen-
dent on the visibility of the structure. Next we intersected the
urethra and prostate. This intersected contour was used later
for determining the center of mass, which eliminated the effect
of uncertainty from the urethra contours superior and inferior
to the prostate. The distance of the centroids of intersected
urethra on the transformed IntraOP and original PreOp images
was measured.
2.E. Statistical testing
The change of dosimetric endpoints was tested with a two-
tailed Wilcoxon signed-rank test or Wilcoxon rank-sum test.
The significance level was defined as p = 0.05. The Pearson
correlation coefficient r was calculated to quantify the linear
relationship between the change of dosimetry and the inflation
of probe cover, which is related to the degree of prostate
deformation. All statistical analysis was performed using the
 Statistics Toolbox version 2014b (Natick, MA).
3. RESULTS
3.A. Prostate deformation and image registration
Qualitatively, there was a significant prostate deforma-
tion from the inflation of the ultrasound rectal probe cover.
Figure 2 demonstrates the difference in prostate shape before
(a) and after (b) cover inflation with the calcification marked.
With the established correspondence by the aforementioned
deformable image registration, contour and seed locations
on the IntraOp (deformed) image could be transferred to the
PreOp (undeformed) image. The displacement of all
calcification landmarks between two registered images was
1.5 ± 1.0 mm on average (n = 57; 32 out of 34 patients).
The signed displacements in the x (patient left–right), y
(patient anterior–posterior), and z (patient superior–inferior)
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F. 2. Prostate deformation resulting from the inflation of the ultrasound
rectal probe cover during the seeds implant. (a) PreOp image when the cover
is not inflated. (b) IntraOp image when the cover is inflated to elevate the
prostate. Red arrow points to the inflated area by probe cover. Light blue
arrows point to a calcification in both images. (See color online version.)
directions were−0.01±0.10, 0.07±0.17, and 0.83±1.64 mm,
respectively. The higher average displacement of calcifica-
tion landmarks in the patient superior–inferior direction was
caused by the bigger pixel size in this direction (1 vs 0.12 mm
in the other two directions). The displacement of the centroid
of the urethra contour inside the prostate was 1.9± 1.1 mm
(n= 34). The Dice index between the transferred contour and
the original contour was 0.86±0.05 (n = 34). These indicate
that the image registration and transformation of seed positions
are relatively accurate.
3.B. Dosimetric change between PreOp
and IntraOp images
A clinical treatment plan was generated from the IntraOp
image [Fig. 3(a)]. The contour, isodose line, and seed positions
are displayed on one transverse slice of a sample patient. The
seed locations were optimized based on the contours of the
prostate and normal structures. When this IntraOp image was
registered with the PreOp image using the deformable registra-
tion algorithm, the seeds on the clinical plan were also mapped
onto the PreOp image. After the seeds on the PreOp image
were identified in VariSeed software, the dose distribution was
calculated [Fig. 3(b)]. Compared with the dose distribution on
the PreOp image [Fig. 3(a)], the 100% isodose line, shown
as the green isoline, shifted anteriorly and the 150% isodose
line, shown as the yellow isoline, moved closer to the urethra.
The overall change of 3D dosimetry of this sample patient is
demonstrated in the DVH in Fig. 3(c). A slight reduction of
the prostate coverage was evident, from a V100% of 96.4% on
F. 3. Prostate seeds mapped from the deformed image to undeformed
image and associated dosimetry for a representative patient. (a) Seeds and
isodose curves on the clinical plan based on the IntraOp ultrasound image.
Red contour is the prostate, blue contour is the rectum, and green circle is
the urethra. Solid green circle with cross represents the implanted seed in
VariSeed software. (b) Dosimetry based on the undeformed PreOp ultrasound
image using seed positions mapped from the deformable registration. Solid
green circle is the seed to be implanted and a green triangle points to a seed
in a neighboring slice. (c) DVHs of sample clinical plan based on the IntraOp
image (solid line; prostate deformed) and research plan based on the PreOp
image (dashed line; prostate undeformed). (See color online version.)
the IntraOp image to 93.4% on the PreOp image. Rectal dose
was found to decrease as well, from a V100% of 0.49 cm3 on
the IntraOp image to 0 cm3 on the PreOp image. The urethra
DVH shifted right for this patient, with the D1% increased
from 192.0 to 250.3 Gy.
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T II. Comparison of dosimetry for the prostate, rectum, and urethra in
deformed vs undeformed anatomy.
Deformed anatomy Undeformed anatomy P
Prostate V100% 95.6% ± 1.7% 92.6% ± 3.8% <0.01
Prostate D90% 113.8% ± 4.0% 107.4% ± 9.8% <0.01
Rectum V100% 0.48 ± 0.39 cm3 0.06 ± 0.14 cm3 <0.01
Urethra V150% 0.02 ± 0.06 cm3 0.11 ± 0.10 cm3 <0.01
Urethra D1% 203.5 ± 22.7 Gy 239.5 ± 25.6 Gy <0.01
The statistical data of all patients (n= 34) are summarized
in Table II. The coverage of the prostate dropped from 95.6%
±1.7% in the clinical plans to 92.6%±3.8% in the research
plans (p < 0.01). The D90% showed a similar trend, changing
from 113.8%± 4.0% to 107.4%± 9.8% (p < 0.01). Qualita-
tively, the drop in dose coverage occurred more at the posterior
side of the prostate next to the rectum. As shown in Fig. 3(b),
the posterior seeds are shifted more in the anterior direction
than the anterior seeds. This agrees with our observation of
calcification landmarks. The prostate volume did not show
significant differences (p > 0.05) between the PreOp image
(33.9± 10.9 cm3) and the IntraOp image (34.2± 11.1 cm3).
The rectum showed better sparing in the research plans, with
the V100% decreased from 0.48 ± 0.39 to 0.06 ± 0.14 cm3
(p < 0.01). However, the urethra received a higher dose in the
research plans, with the V150% increasing from 0.02±0.06
to 0.11±0.10 cm3 (p < 0.01) and D1% increasing from 203.5
±22.7 to 239.5±25.6 Gy (p < 0.01).
Inflation of the ultrasound probe cover was measured for
all patients and plotted with the change of prostate V100%,
rectum V100%, and urethra D1% from the clinical plan to
research plan (Fig. 4). The Pearson’s correlation coefficients
(r) were −0.30, −0.37, and 0.04 when a linear regression
was made between the changes of prostate V100%, rectum
V100%, and urethra D1% and inflation of the probe cover,
respectively. This suggests a weak correlation between the
displacement and the change of prostate V100% and rectum
V100%. The median value of inflation was 6.8 mm. Patients
were distributed into two groups, one with relatively small
inflation (d < 6.8 mm; n = 17) and the other with relatively
large inflation (d ≥ 6.8 mm; n = 17). The rectum V100%
shows a significant difference between the two groups as indi-
cated in Table III.
4. DISCUSSION
There has been a large body of literature demonstrating the
importance of prostate seed implant dosimetry. Correlation
has been discovered between poor implant quality and high
failure rates.18 Many studies have also reported that D90%
and V100% of the prostate are correlated with treatment
outcome.19–21 Similarly, it is recommended that the critical
organ dose parameters, such as the urethra V150, urethra
maximum dose (or D1%), and rectum V100%, are to be
limited to reduce the side effects.22 Thus it is very useful to
know the accurate dosimetric parameters without the tempo-
rary large organ deformation during the procedure.
F. 4. Change of dosimetric endpoints from the deformed image (clinical
plan) to the undeformed image (research plan). (a) Prostate V100%. (b)
Rectum V100%. (c) Urethra D1%.
To our knowledge, this is the first study to examine the
impact of the inflated ultrasound rectal probe cover on the
dosimetric characteristics in prostate brachytherapy. Adjusting
for tissue deformation has been an important topic in the field
of radiation therapy. Deformable image registration has been
used for structure/target delineation, dose accumulation, and
to facilitate adaptive radiation therapy.23–25 While a number
of deformable registration methods have been developed for
computed tomography (CT) images,26 there is a general lack
of established methods for ultrasound images and learning-
based methods.10–12 Thus, our study is novel for develop-
ing such a method and using it for a clinical study. Our
registration method is intensity-based. Unlike feature-based
registration methods, our method does not need to compute the
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T III. Changes in dosimetric endpoints from the deformed image to the undeformed image caused by the
inflation of ultrasound probe cover.
Small inflation (d < 6.8 mm) Large inflation (d ≥ 6.8 mm) P
Prostate V100% −2.4% ± 2.7% −3.4% ± 3.3% 0.19
Rectum V100% −0.30 ± 0.32 cm3 −0.55 ± 0.39 cm3 0.04
Urethra D1% 35.0 ± 21.0 Gy 34.7 ± 18.7 Gy 0.72
features within the images prior to registration. Additionally,
our method employs mutual information as the similarity
metric, so it is insensitive to intensity shift between image
acquisitions. On the other hand, our method only uses the
conventional mutual information and does not consider the
spatial information of the image to facilitate registration.
The evaluation of registration accuracy involved calcification
points. In some patient, there is no clear calcification or the
calcification is quite large. More reliable landmarks such as
gold fiducials will be used in future efforts to further verify the
accuracy of image registration. The registration uncertainty of
1.5 mm found in this study, primarily in the superior-inferior
direction, could partially contribute to the reported change in
dosimetry; however, we do not believe that it is the main factor.
Through deformable image registration and subsequent
dosimetric analysis, we found on the less deformed image that
the coverage of the prostate decreased, the rectum was less
irradiated, and the urethra received higher dose. The clinical
implication of this work is that during a real-time prostate
brachytherapy procedure, treatment planning may need to
consider the magnitude of prostate deformation from the
ultrasound rectal probe cover. Our results show that physicians
and physicists may be compromising prostate coverage when
attempting to meet the rectal dose constraint during planning.
This result is only based on ultrasound images acquired prior
to the seed implant during the procedure without the inflation
of probe cover. As part of our standard clinical practice, each
patient underwent postimplant CT one month postbrachyther-
apy. Dosimetry is verified based on the CT information. While
this is clinically meaningful (avoiding gross over/under dosing
of interested structures), it is less sensitive to detect the kind of
difference we are investigating in this study. It is known that the
volume of prostate on pretreatment ultrasound image and post-
treatment CT can be 20% different.27 This is largely due to the
fact that CT imaging does not delineate the prostate accurately
(overestimates). There are notable difficulties distinguishing
the prostate from other tissues on CT images, especially with
the artifacts caused by the implanted metal seeds. Therefore,
while we agree that it would strengthen our work with CT
dosimetry post-treatment, we do not feel that it is necessary
to include in this study. We are devising plans to conduct
such a study with more accurate prostate delineation, possibly
utilizing MR imaging. In addition, the accumulated dosimetry,
especially dose on normal structures, may need more frequent
imaging after the procedure to capture the average state of
organs. Dosimetry reported in this study was derived on
less deformed ultrasound images, instead of more deformed
planning image. Therefore, it should be closer to accumulated
ideal dosimetry than original planning dosimetry.
Reports on early series of men who underwent a postim-
plant CT scan for dosimetry purposes showed that cases with
a D90 value above a cut point had significantly better prostate-
specific antigen (PSA) control than cases below the cut point.
This implied that there was a dose–response relationship for
local control of the cancer within the prostate.21,28,29 Zelefsky
and Whitmore reported the assessment of the 15-year outcome
of the historical series of retropubic freehand implants per-
formed at the Memorial Sloan-Kettering Cancer Center and
found that the technique was associated with a greater than
expected incidence of local relapse at 15 years. They identified
suboptimal dose distribution due to the technical limitations as
the possible cause of the unfavorable outcome.30 The improve-
ment of dosimetry from our method is most likely incremental
and may not change the long term disease control for the
overall patient population, but for certain patients with large
deformation of the prostate during the implant, the dosimetric
change may be large enough to cause a difference of treatment
outcome. This warrants further long-term investigation to
quantify how deformation affects dosimetry and local control.
5. CONCLUSIONS
In conclusion, we developed a deformable image regis-
tration method that allows a dosimetric estimation using the
images of the undeformed prostate. Our study demonstrates
that the deformation caused by the inflated probe cover signif-
icantly affects the real dose to the target and normal or-
gans in prostate brachytherapy. Our data suggest that treat-
ment planning using images of the deformed prostate can
overestimate coverage of the target, rectal dose, and sparing
of the urethra. Our method of deformable mapping can be
integrated into existing clinical treatment planning tools to
account for prostate deformation and report more accurate
dosimetry.
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APPENDIX: ALGORITHM OF IMAGE REGISTRATION
Here T0 is the average of transformations between deformed
and undeformed images from other patients in the training set
based on the cylindrical coordinate system.
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A I. Deformable registration between the deformed and undeformed images of the same patient.
Step. 1. Detect the centers of the probes in both deformed and undeformed images at the central slice as the
original.
Step. 2. Establish cylindrical coordinate systems for deformed and undeformed images with the z-axis
(patient superior–inferior direction).
Step. 3. Set transformation T as the initialization T0.
Step. 4. Transfer IIntraOp to IPreOp of a same patient in the testing set by the deformable transformation T .
Step. 5. Compute mutual information between IPreOp and I ′IntraOp (transferred IIntraOp) as a similarity criterion.
MI(IPreOp, I ′IntraOp)=H (IPreOp)+H (I ′IntraOp)−H (IPreOp, I ′IntraOp)
Step. 6. If the mutual information does not converge, set T =T +△T , and go to Step. 4, otherwise stop.
Step. 7. Obtain the optimal transformation.
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